Crosstalk between the Gut Microbiome and Colonic Motility in Chronic Constipation: Potential Mechanisms and Microbiota Modulation
Open accessThe DOI matches its Crossref record; 164 of the 166 references it cites were found in a registry or an index.
Abstract
Chronic constipation (CC) is a highly prevalent and burdensome gastrointestinal disorder. Accumulating evidence highlights the link between imbalances in the gut microbiome and constipation. However, the mechanisms by which the microbiome and microbial metabolites affect gut movement remain poorly understood. In this review, we discuss recent studies on the alteration in the gut microbiota in patients with CC and the effectiveness of probiotics in treating gut motility disorder. We highlight the mechanisms that explain how the gut microbiome and its metabolism are linked to gut movement and how intestinal microecological interventions may counteract these changes based on the enteric nervous system, the central nervous system, the immune function, and the ability to modify intestinal secretion and the hormonal milieu. In particular, microbiota-based approaches that modulate the levels of short-chain fatty acids and tryptophan catabolites or that target the 5-hydroxytryptamine and Toll-like receptor pathways may hold therapeutic promise. Finally, we discuss the existing limitations of microecological management in treating constipation and suggest feasible directions for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, inactive probiotics and heat-inactivated probiotics have been shown to be effective in improving constipation [26,57], suggesting that they may have advantages over some live probiotics in terms of stability and safety for patients with compromised enterobacterial defenses of treatment.”
From Chronic constipation and gut microbiota: current research insights and therapeutic implications (2024) · cites this paper as [26]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Furthermore, inactive probiotics, such as probiotic metabolites, have shown effectiveness in improving constipation [26], suggesting that these inactive components may serve as an alternative microbial therapy for treating constipation in patients with impaired intestinal bacterial defenses.”
From Chronic constipation and gut microbiota: current research insights and therapeutic implications (2024) · cites this paper as [26]
In the citing paper
“The mechanism by which BAs affect colonic motility involves the activation of BA receptors, which then stimulate the release of 5-HT and calcitonin gene-related peptides by the enterochromaffine cells and primary afferent neurons in the intestine, triggering the intestinal peristalsis ref lex [26,33].”
From Chronic constipation and gut microbiota: current research insights and therapeutic implications (2024) · cites this paper as [26]
In the citing paper
“Probiotic therapy acts through a mass effect, which alleviates symptoms of constipation by modulating the intestinal microenvironment, intestinal epithelial immune response, intestinal secretory function, and the neuroendocrine system that inf luences intestinal motility and secretion [6,22,26].”
From Chronic constipation and gut microbiota: current research insights and therapeutic implications (2024) · cites this paper as [26]
In the citing paper
“In addition, inactive probiotics and heat-inactivated probiotics have been shown to be effective in improving constipation [26,57], suggesting that they may have advantages over some live probiotics in terms of stability and safety for patients with compromised enterobacterial defenses of treatment.”
From Chronic constipation and gut microbiota: current research insights and therapeutic implications (2024) · cites this paper as [26]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Guarino, M., Cheng, L., Cicala, M., Ripetti, V, Biancani, P., & Behar, J. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01705.x · Cited by 44 · cited 3×
“Notably, overexpression of P4R has been found in accessible tissues, such as epithelial cells [98], the circular muscle layer [100], and the outer layer of the muscularis propria [102], suggesting that these abnormalities play a pivotal role in the pathogenesis of constipation.”
BackgroundRetractedHill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
Agus, A., Planchais, J., & Sokol, H. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.003 · Cited by 3,180 · cited 1×
“This observation highlights a potential mechanism that links tryptophan metabolism to functional GI disorders [35].”
BackgroundA framework for human microbiome research
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11209 · Cited by 2,650 · cited 1×
“This has contributed to an understanding of the roles that certain microbes and microbial mediators play in constipation [6].”
BackgroundZelante, T., Iannitti, R. G., Cunha, C., De Luca, A., Giovannini, G., Pieraccini, G., Zecchi, R., D’Angelo, C., Massi-Benedetti, C., Fallarino, F., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.003 · Cited by 2,614 · cited 2×
“In addition, indole metabolites of Lactobacillus were shown to affect the TH17 cell/Treg balance [130] and mucosal homeostasis via IL-22, thereby attenuating intestinal inflammation in an AHR-dependent manner [56].”
BackgroundSayin, S. I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., & Bäckhed, F. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.003 · Cited by 2,331 · cited 1×
“Other products of bacterial fermentation [66], such as bile acids and methane, also affect ENS function (Figure 1 and Table 2).”
BackgroundMicrobial tryptophan catabolites in health and disease
Roager, H. M., & Licht, T. R. (2018) · Nature Communications · doi:10.1038/s41467-018-05470-4 · Cited by 2,236 · cited 2×
“gallinarum Breaking down tryptophan and modulation of gut microenvironment to improve colon function [110,111] Animal”
BackgroundPeng, L., Li, Z.-R., Green, R. S., Holzmanr, I. R., & Lin, J. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.104638 · Cited by 2,130 · cited 2×
“Intestinal barrier Activation of AMP-activated protein kinase [49] Stimulating tight junction signaling and the expression of mucin-associated peptides [50] Modulation of goblet cells to release specific mucins, such as MUC2 [51] Cell Animal Animal”
Background
Cited by
Items 101–154 of 154
Impact of Physical Activity on Digestive System Diseases
Zabawa, B., Sadowski, J., Mól, P., Papież, Ł. S., Dołęga, J., Krzykawski, K., Maciejczyk, T., Sieńko, A., Łabuś, M., & Hudzińska, P. (2024) · Quality in Sport · doi:10.12775/qs.2024.34.56112 · Cited by 2
Shi, L., Gao, J., Liu, J., Li, Y., Yang, H., Qu, B., Chen, K., Pu, X., Cai, S., Liu, L., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120330 · Cited by 2
Lin, P., Wang, W., Zhou, Y., Yang, Y., & Ping, L. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02570-1 · Cited by 2
“Activated immune cells release inflammatory cytokines and neurotransmitters, causing disrupted mucosal barrier and abnormalities in gut sensation and motility [20].”
Dong, X., Chen, M., Liu, H., Zhou, S., Sun, M., Wang, L., Li, Y., Zhang, H., Xu, C., Wang, B., et al. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128328 · Cited by 1
Self-citationExtrasphincteric anal fistula with gluteal extension: A case report and literature review
Chen, J., Peng, W., Yu, D., Liang, Q., & Chen, J. (2025) · Medicine · doi:10.1097/md.0000000000045818 · Cited by 1
Zhang, H., Tu, J., Pang, Y., Ma, J., Zhang, L., Xue, C., Liu, Y., Hong, W., Hui, M., Li, B., et al. (2026) · Food Research International · doi:10.1016/j.foodres.2026.118515 · Cited by 1
Li, H., Ye, A., Song, J., Yang, Y., & Li, J. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1852596 · Cited by 1
“These substances can act directly on ENS neurons or in fl uence the CNS via circulatory or neuroendocrine pathways (Pan et al., 2022).”
Du, Y., Zhang, Z., Huang, W., Gao, W., & Li, X. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.122105 · Cited by 1
Zheng, F., Yang, Y., Zhan, Y., Zhang, Z. W., Lu, G., Xie, D., Zhang, S.-M., Mageswary, M. U., Lee, Y. W., & Liong, M. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1876944 · Cited by 1
“Mechanistically, this improvement is likely linked to modulation of the gut microbiota and attenuation of low-grade intestinal inflammation, which are recognized contributors to functional constipation (7, 44).”
Coman, M. M., Egidi, N., Silvi, S., Leone, R. D., & Verdenelli, M. C. (2024) · Fermentation · doi:10.3390/fermentation10100518 · Cited by 1
Kakamousias, A., & BLAKE, K. D. (2025) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.64141 · Cited by 1
Natalello, G., Lorenzis, E. D., D’Agostino, M. A., Langella, P., Bréban, M., Cherbuy, C., & Bazin, T. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.104038 · Cited by 1
Long‐Term Gastrointestinal Outcomes in Children Exposed in Utero to Maternal Chronic Hypertension
Roguin, N., Gutvirtz, G., Pariente, G., Wainstock, T., & Sheiner, E. (2026) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.70148 · Cited by 1
“Since obesity is a well-established risk factor for various gastrointestinal disorders, including pancreatitis, colonic disease, and complicated appendicitis [22–24], the inability to account for it may confound our findings.”
The curious case of lubiprostone—same daily dose but different response?
Bolia, R. K. (2024) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/jpn3.12207 · Cited by 1
Constipation targeted monostrain and multispecies probiotics: effects on symptoms and gut microbiota
Zeng, Y., He, P., Lyu, C., Wu, Y., Zhao, X., Gu, Q., Wu, S., Zhang, Y., Wei, X., An, R., et al. (2025) · Food Science and Human Wellness · doi:10.26599/fshw.2025.9250509 · Cited by 1
Dendrobium nobile in the Management of Gastrointestinal Disorders
Sarsaiya, S., Jain, A., Gong, Q., Wu, Q., & Shi, J. (2025) · CABI eBooks · doi:10.1079/9781800627987.0010 · Cited by 1
Tiburcio, Á. Z. (2022) · Gastroenterology Medicine & Research · doi:10.31031/gmr.2022.07.000658
Gong, Z., Li, T., Du, Y., Yan, H., Xu, M., Lian, Y., Wei, W., & Liu, T. (2023) · Research Square · doi:10.21203/rs.3.rs-3730536/v1 · Cited by 1
Modulation of gastrointestinal transit by circadian rhythms and lifestyle
Jensen, M. M. (2023) · VBN Forskningsportal (Aalborg Universitet) · doi:10.54337/aau617103795
Features of preparation for colonoscopy of patients with chronic constipation
Seliverstov, P. V. (2024) · Vrach · doi:10.29296/25877305-2024-07-12
Pan, R., Xu, X., Chen, Y., Wang, H., Wang, L., Tian, P., Jin, X. Y., Zhao, J., Chen, W. J., & Wang, G. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250232
Self-citationDiet and Disease Development: Present and Future
Saad, S. (2024) · Nutrients · doi:10.3390/nu16213681
Piao, Y., Luo, J., Ren, T., Wang, A., Li, Y., Pan, L., Li, X., Li, F., Bao, Y., Zheng, F. Y., et al. (2025) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.10065
Shen+, Y., Xie, S., Lin, Y., Fang, Y., Zhang, B., & Zhang, J. (2025) · Tobacco Induced Diseases · doi:10.18332/tid/203866
Yang, W., Jiang, C., Shao, Y., Gu, S., & Hong, M. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1594644 · Cited by 1
Constipation Following Immune Checkpoint Inhibitor Therapy
Menon, R., Wali, S., Ahuja, R., Black, S., Pabani, A., Grover, S., Garg, S., Song, G., Thomas, A. S., Viswanathan, L., et al. (2025) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-025-00479-3
Lin, L., Ren, Q., Han, X., Ji, F., Geng, S., Liu, S., & Mao, J. (2025) · Food Nutrition · doi:10.1016/j.fnutr.2025.100037
Lellis, L. F. D., Toledano-Marín, Á., Navarro-Moreno, M., Caiazzo, E., Madonna, G., Delgado-Osorio, A., Buccato, D. G., Izzo, L., Paolillo, A., Minno, A. D., et al. (2025) · Foods · doi:10.3390/foods14213800 · Cited by 1
Zhu, L., Gao, H., Li, Q., Wang, Y., Li, J., Li, X., Huang, Z., Wang, C., & Nie, J. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1705271 · Cited by 1
“Notably, Escherichia – Shigella remained elevated post-intervention in non-responders, who showed minimal symptomatic improvement, reinforcing its role in persistent FC (Ohkusa et al., 2019; Pan et al., 2022).”
Nguyen, N. T. T., Hertanti, N. S., & Chuang, Y. (2025) · Journal of Renal Care · doi:10.1111/jorc.70040
Targeting Gut Microbiota in the Management of Functional Constipation: A Narrative Review
Takeda, T., Hojo, M., Asaoka, D., & Nagahara, A. (2025) · Internal Medicine · doi:10.2169/internalmedicine.6457-25 · Cited by 1
Li, H., & Wang, H. (2026) · Medicine · doi:10.1097/md.0000000000046853
“[17] Furthermore, specific coffee components may regulate intestinal smooth muscle contraction and relaxation via effects on calcium channels.”
Self-citationGuo, D., Yj, S., Yuan, L., Chu, W., Dong, Y., & Wang, D. (2026) · Postgraduate Medicine · doi:10.1080/00325481.2026.2619422
“…is outlined as follows: First, FC is often associated with a decreased abundance of short-chain fatty acid (SCFA)-producing bacteria (e.g. Bifidobacterium, Lactobacillus) in the gut, along with potential enrichment of pathogenic bacteria such as Escherichia coli and Staphylococcus aureus [29–31].”
Jeong, S.-N., & Kim, M.-J. (2026) · Scientific Reports · doi:10.1038/s41598-026-37864-6
Hajek, P., Valentini, L., Büning, C., Schöneberg, T., Bischoff, S. C., & Meier, N. (2026) · Aktuelle Ernährungsmedizin · doi:10.1055/a-2763-0269
Sun, W., Li, Y., Su, J., Mao, S., Yang, S., Zhu, Y., Liu, Y., Ma, J., You, W., Zhang, Y., et al. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1744020
“Disruption of this balanced ecosystem, termed gut dysbiosis, has been increasingly implicated in the pathogenesis of CFC, where patients frequently exhibit reduced levels of bene fi cial microorganisms alongside the expansion of potentially harmful taxa (Ohkusa et al., 2019; Pan et al., 2022).”
Stroke Severity and Constipation in Ischemic Stroke Patient in Indonesian Regional Hospital
Purwandhono, A., Robby, S. A. R., Sofiana, K. D., Narwanto, M. I., & Adji, N. K. (2026) · Majalah kedokteran Bandung/Majalah Kedokteran Bandung · doi:10.15395/mkb.v58.4276
Mariaule, V. (2024) · theses.fr (ABES) · doi:10.70675/1d41e841zf788z4dd7z8784zc26304e24ea1
Rodenes-Gavidia, A., Mas‐Capdevila, A., Florit, A., López, M. E., González‐Hedström, D., Lamelas, A., Martorell, P., Chenoll, E., Illescas, V., Martínez-Blanch, J. F., et al. (2026) · Nutrients · doi:10.3390/nu18081237
“LPS can stimulate the production of pro-inflammatory cytokines such as tumor necrosis factor (TNF)- α and interleukin (IL)-6) by macrophages via the TLR4/nuclear factor kappa B (TNF-κ B) pathway, thereby inducing systemic inflammation [77].”
Lactiplantibacillus plantarum Z6 Improves Functional Constipation in Infants
Zhou, X., Hu, G., Wu, J., Duan, Y., Zhu, B., Deng, W., Shen, Y., Wang, X., Li, S., Wei, J., et al. (2026) · Biotechnology Journal · doi:10.1002/biot.70233
“Prior studies have also suggested that L. plantarum may influence 5-hydroxytryptamine (5-HT)- related signaling, which is involved in the regulation of intestinal peristalsis [16–18].”
Önning, G., Vegge, C. S., Montelius, C., Lewis, E. D., Al‐Wahsh, H., Moulin, M., Crowley, D. C., & Guthrie, N. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.v32.i21.117959
Jiang, H., Zhang, H., Ding, X., Youwe, W., Wu, C., Peng, A., Cao, D., Wang, J. R., Zeng, W., & Zhu, F. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.03138-25
Zhou, X., Guo, C., Hu, G., Ding, L., Zou, T., Wang, M., Xiong, W., Deng, W., Wei, J., Yu, J., et al. (2026) · Biotechnology Journal · doi:10.1002/biot.70250
Al‐Beltagi, M. (2026) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.120203
Liu, J., Li, M., Xin, Q., Li, C. J., Li, A., Zhang, G., Yu, R., Du, P., & Liu, L. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.109308
Uspenskiy, Y. P., Fominykh, Y. A., & Matveeva, E. O. (2026) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-246-2-51-60
Chen, Y., Duan, W., Du, M., Guo, M., & Sun, Y. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1817279 · Cited by 1
“These strategies aim to regulate microbial composition, enhance metabolite production and improve intestinal barrier function, potentially overcoming the limitations of traditional laxatives that only relieve symptoms without addressing underlying causes (Araújo and Botelho, 2022; Pan et al., 2022).”
Self-citationKim, W. I., Lee, T., Kim, C.-J., Kim, Y.-J., Seo, I.-S., Sj, A., Kim, J.-Y., Jung, S.-E., Kim, G.-W., Song, E., et al. (2026) · Letters in Applied Microbiology · doi:10.1093/lambio/ovag063
Gabriel, E. M., Nooriankafshgari, F., García‐Sierra, R., Vallvé, C. S., Parellada-Moreno, D., Ruesjas, V. A., Herrero, I., & Torán‐Monserrat, P. (2026) · Healthcare · doi:10.3390/healthcare14182928
Slover, W. K., D’Alessandro, N. B., Dutta, P., Vippa, T. K., D’Souza, S. M., Oldfield, E. C., & Johnson, D. A. (2026) · Microplastics · doi:10.3390/microplastics5040194
“Such pathogenic shifts in the microbial landscape may underpin abnormal intestinal transit, which is a hallmark of clinical conditions like irritable bowel syndrome and chronic constipation [32,37].”
Zhu, J., Zeng, B., Zhu, W., Liu, Y., Li, X., Zhang, Y., Xu, Z., Xu, Q., Wu, W., Li, J., et al. (2026) · iScience · doi:10.1016/j.isci.2026.117850
Pilot Study of a Herbal Formulation Composed of Bidens pilosa for Constipation in Humans
Kuo, T., Lee, Y., Yang, G., Liang, Y., & Yang, W. (2026) · eFood · doi:10.1002/efd2.70205
Jiang, P., 杨小清, 张城浩, Li, Y., & Xu, C. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1941480
“…understood as a gut motility disorder embedded in host–microbiome crosstalk, as dysbiosis and microbial metabolites may influence intestinal movement through enteric and central neural, immune, secretory, hormonal, short-chain-fatty-acid, and 5-hydroxytryptamine-related pathways (Pan et al., 2022).”
Zakharova, I. N., Fayzullina, R. A., Berezhnaya, I. V., Medvedeva, E. A., Pupykina, V. V., & Orobinskaya, Y. V. (2026) · Pediatrics Consilium Medicum · doi:10.26442/26586630.2026.3.203812
Metadata
- Authors
- Pan, R., Wang, L., Xu, X., Chen, Y., Wang, H., Wang, G., Zhao, J., & Chen, W.
- Affiliations
- Jiangnan University (CN)
- Wuxi People's Hospital (CN)
- Corresponding author
- Wang, Haojue
- Zhao, Jianxin
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2022-09-08
- Volume
- 14
- Issue
- 18
- Pages
- 3704
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC9505360
- OpenAlex
- W4296117667
- Cited by
- 149
- References
- 166
- Citations by year
- 2026: 33 · 2025: 55 · 2024: 41 · 2023: 17 · 2022: 3
- FWCI
- 5.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- the National Natural Science Foundation of China (32172213, 31972052, 32021005, 31820103010, JUSRP22006, JUSRP51501, M202007, 2020X018, bj2020111, FYTG202006, Y202104)
- Fundamental Research Funds for the Central Universities (32172213, 31972052, 32021005, 31820103010, JUSRP22006, JUSRP51501, M202007, 2020X018, bj2020111, FYTG202006, Y202104)
- Program of Collaborative Innovation Centre of Food Safety and Quality Control in Jiangsu Province (32172213, 31972052, 32021005, 31820103010, JUSRP22006, JUSRP51501, M202007, 2020X018, bj2020111, FYTG202006, Y202104)
- Scientific Research Project Plan of Wuxi Municipal Health Commission (32172213, 31972052, 32021005, 31820103010, JUSRP22006, JUSRP51501, M202007, 2020X018, bj2020111, FYTG202006, Y202104)
- Wuxi Science and Technology Plan Project (32172213, 31972052, 32021005, 31820103010, JUSRP22006, JUSRP51501, M202007, 2020X018, bj2020111, FYTG202006, Y202104)
- Top Talent Support Program for Young and Middle-aged People of Wuxi Health Committee (32172213, 31972052, 32021005, 31820103010, JUSRP22006, JUSRP51501, M202007, 2020X018, bj2020111, FYTG202006, Y202104)
- Appropriate Technology Promotion Project of Wuxi Municipal Health Commission (32172213, 31972052, 32021005, 31820103010, JUSRP22006, JUSRP51501, M202007, 2020X018, bj2020111, FYTG202006, Y202104)
- Innovation Nurturing Fund project of Wuxi Xishan People’s Hospital (32172213, 31972052, 32021005, 31820103010, JUSRP22006, JUSRP51501, M202007, 2020X018, bj2020111, FYTG202006, Y202104)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- chronic constipation, gut microbiota, colonic motility, probiotics, short-chain fatty acids, tryptophan catabolites, serotonin, Toll-like receptors, enteric nervous system, gut-brain-immune axis, intestinal secretion, microbiota modulation
- MeSH terms
- Gastrointestinal Microbiome, Constipation, Fatty Acids, Volatile, Humans, Serotonin, Tryptophan, Toll-Like Receptors, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.